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Background:
 
 Time-to-reperfusion, electrocardiographic and angiographic
parameters are of prognostic relevance in ST-elevation myocardial infarction
(STEMI) patients. We sought to evaluate predictors of Infarct size (IS) and
presence of microvascular obstruction (MO) using delayed hyper-enhance-
ment magnetic resonance imaging (CMR).
 
Methods and results:
 
 We analyzed 128 consecutive STEMI patients reper-
fused by primary PCI within 12 hours after symptom onset. IS and MO were
assessed by delayed hyper-enhancement MRI as percentage of LV mass, 4±2 days
after acute MI. Reperfusion times, TIMI-flow grades pre and post PCI, 90 min ST-
segment resolution, cardiovascular risk factors, Killip-class, and infarct location
were assessed. In patients with TIMI flow 0-1 before PCI, IS was significantly
higher compared to patients with TIMI-flow 2-3 (22±12% versus 16±15%;
p<0.01). Similarly, the extent of MO occurrence was affected by the pre PCI TIMI
flow. A trend toward higher final IS and MO was noted in post PCI TIMI flow.
Patients with TIMI flow 0 to <3 IS was 28±11% versus 20±12% in TIMI-flow =3
(p=0.067). The ST-segment resolution correlated inversely with final IS and pres-
ence of MO (IS r=-0.34, p<0.01; MO r=-0.31, p<0.01). IS was significantly higher
in anterior AMI versus inferior AMI (24±16% versus 17±12%; p<0.01 as well as
MO (9.8±7.8%vs. MO 4.8±3.7%; p=0.01). In a multivariable model the strongest
predictors of IS and MO were pre-PCI TIMI-flow, infarct location, admission
Killip class, and 90 minute ST-segment resolution (p<0.05 for all).
 
Conclusions:
 
 The pre-PCI TIMI flow, infarct location, Killip class and ST-
segment resolution are the strongest predictors of IS and extent of MO as
assed by delayed Hyper-enhancement MRI. CMR allow for strong evaluation
in STEMI patients, giving important information regarding prognostic.
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sPLA2 and Lp-PLA2 are currently being evaluated as potential markers and
therapeutic targets in coronary artery disease. We hypothesized that their mea-
surement, in parallel with CRP, could correlate to the risk of death or myocardial
infarction (MI) in patients with suspected acute coronary syndromes (ACS), pro-
viding thereby important prognostic information. We therefore analysed a cohort
of 419 unselected consecutive patients (mean 61.1 years old ; 63.9 % male) pre-
senting in the emergency room of a large tertiary hospital, without ST-segment
elevation (NSTE) on the baseline ECG, with chest pain (72 %) or other clinical
features considered indicative of ACS. Clinical history, basal troponin I (cTnI)
and CRP measurements were obtained. Final discharge diagnoses were assigned
to the following categories: NSTE-ACS including NSTE-MI and unstable angina
(UA), other cardiac diseases (OCD) or non cardiac diseases (NCD). Follow-up
was obtained in all patients at 40 days. sPLA2 mass, sPLA2 and Lp-PLA2 activ-
ities were measured on the serum samples collected at presentation. The median
sPLA2 activity was significantly higher in NSTE-ACS patients (1.89), than in
OCP and NCP patients (1.45 and 1.43 respectively; p< 0.001). A significant asso-
ciation between sPLA2 mass and diagnosis (p<0.02) was also found, while the
Lp-PLA2 activity appeared not to be associated with the final diagnosis. Patients
with sPLA2 activity or mass at presentation in the highest quartile had a statisti-
cally higher incidence of cardiac death and MI than those with sPLA2 activity or
mass in the lowest quartile (37.5% versus 13.4 %, p=0.0001 and 33.6% versus
16%; p=0.0047, respectively). On the other hand, no association was observed
with Lp-PLA2 activity. Therefore, a single measurement of sPLA2 activity in
 
unselected patients presenting with suspected ACS and no ST-segment elevation,
provides better independent prognostic information than either CRP, sPLA2 mass
or Lp-PLA2, on the risk of death or MI.
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Background:
 
 Erythrocytes transfusion is an independent risk factor for
recurrent ischemic events and mortality in patients suffering from acute coro-
nary syndrome. There is no evidence regarding the underlying mechanism of
such association.
 
Aim:
 
 We hypothesized that red blood cell transfusion would activate
platelet aggregation and we sought to identify which are the pathway involved
in this activation process.
 
Methods:
 
 Healthy volunteers (n=15) provided blood samples that were
mixed with red blood cell (tRBC) obtained from transfusion packs. We
explored platelet activation using light transmission agregometry with four dif-
ferent agonist (ADP, Arachidonic Acid (AA), Collagen and Epinephrin) in 10
volunteers and with flow cytometry for P-selectin and VASP in 5 volunteers.
Measures were obtained at baseline (whole blood from healthy volunteers),
after in vitro transfusion with a 1:4 ratio of tRBC and after in vitro transfusion
with a 1:4 ratio of tRBC and hematocrit adjustement with platelet poor plasma.
All experiment were performed in duplicates.
 
Results:
 
 Theses are preliminary results from the ongoing TRANSFUSION
study. Numerical values are given in table 1. 1/ RBC transfusion activates
platelet aggregation thought ADP and AA pathway. 2/ This effect was con-
firmed by increase in P-Selectin platelet content with flow cytometry and is
independent of an increase in hematocrit. 3/ P2Y12 activation pathways is
involved with an increase in VASP.
 
Conclusions:
 
 Red Blood Cell transfusion activates platelet thought ADP
and AA pathway in healthy volunteers. This may explain the independent
association between transfusion and recurrent ischemic events including mor-
tality in ACS patients.
 
Results of tRBC induced platelet aggregation
 
010
 
Anemia for Risk Assessment of Patients With Acute Coronary Syndromes
 
Nicolas Meneveau, Francois Schiele, Marie France Séronde, Vincent Desco-
tes-Genon, Joanna Dutheil, Romain Chopard, Yvette Bernard, Jean-Pierre
Basssand
 
CHU Besançon, Cardiologie, Besançon, France
 
Background:
 
 In patients admitted with acute coronary syndromes (ACS),
those with anemia are at higher risk. However, current risk score systems do
not take into account the presence of anemia.
 
n=10 n=5
Technique Aggregometry (Residual 
Platelet Aggregation %)
P-Selection % PRI 
(%)
 
Agonist ADP AA Collagen Epinephrin 20
 
μ
 
M 
ADP
50
 
μ
 
m 
ADP
VAS
P
Baseline 58,0 79,5 61,6 65,0 33,6 40,2 68,4
After tRBC 
(no adjustement)
70,3 89,1 72,5 59,6 50,5 56,4 83,9
After tRBC 
(adjusted with PPP)
48,1 54,5 74,8
p value 0,03*0,04* 0,13 0,15 ND ND ND
 
(*<0,05; ND=not done)
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Methods: 
 
The impact of anemia on mortality was studied, and its incre-
mental predictive value was evaluated. Demographic, clinical, and biologic
characteristics at admission, as well as treatments and mortality, were recorded
for 1,410 consecutive patients with acute coronary syndromes. The incre-
mental value of adding anemia information to risk score evaluation was deter-
mined using changes in the appropriateness of Cox models when anemia was
added.
 
Results:
 
 Anemia was detected in 381 patients (27%). They were older, had
more co-morbidities, had higher Global Registry of Acute Coronary Events
(GRACE) risk scores, received fewer guideline-recommended treatments, and,
as a result, had 4-fold higher mortality. When included in a prediction model
based on the GRACE risk score, anemia remained an independent predictor of
mortality. The addition of anemia improved both the discriminatory capacity
and calibration of the models. According to the GRACE risk score, the popu-
lation was divided into 4 groups of different risk levels of <1%, 1% to <5%,
5% to <10%, and > or =10%. The addition of anemia to the model made it
possible to reclassify 9%, 43%, 47%, and 23% of patients into the different
risk categories, respectively.
 
Conclusion:
 
 Our data confirmed that anemia was an independent predic-
tive factor of mortality and had incremental predictive value to the GRACE
score system for early clinical outcomes.
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Anemia; acute coronary syndromes; risk assessment.
 
011
 
Insights from endogenous thrombin generation in patients undergoing
percutaneous coronary intervention. A cohort study
 
Francois Schiele, Evelyne Raccadot, Nicolas Meneveau, Marie-France
Seronde, Vincent Descotes-Genon, Joanna Oettinger, Kais Mrabet,
Romain Chopard, Jean-Pierre Bassand
 
CHU Besancon, Cardiologie, Besancon, France
 
Background:
 
 Determination of appropriate dosing of antithrombotic drugs
is difficult, and clinical studies to define appropriate monitoring techniques are
needed.
 
Objective:
 
 We compared the endogenous thrombin potential (ETP) in
patients planning to undergo percutaneous coronary intervention (PCI) being
pre-treated with a combination of two or three antiplatelet agents and with
fondaparinux or unfractionated heparin (UFH). Pre-treatment was dependent
upon clinical presentation. Calibrated Automated Thrombography was per-
formed in voluntary blood donors and in patients submitted to PCI. Thrombin
generation was studied in platelet poor plasma by a fluorimetric technique.
 
Patients/Methods:
 
 A total of 152 patients were included. Group 1 patients
were pre-treated with aspirin alone, group 2 were pre-treated with aspirin and
clopidogrel, group 3 were treated with a combination of aspirin, clopidogrel,
and 2.5 mg fondaparinux, group 4 were treated with aspirin, clopidogrel, 2.5
mg fondaparinux, and tirofiban, and group 5 received a bolus of 50 IU/kg
UFH plus antiplatelet agents.
 
Results:
 
 Compared with voluntary blood donors, there was a significant
decrease in ETP in group 2. The addition of fondaparinux (group 3) induced
a 24% decrease in ETP; a further 25% decrease in ETP was observed between
groups 3 and 4. No thrombin generation was observed after UFH treatment.
 
Conclusion:
 
 Assessment of thrombin generation is potentially very useful
in the setting of PCI, where a combination of antiplatelet agents and an anti-
coagulant is mandatory.
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Background:
 
 Cardiac magnetic resonance imaging (MRI) is the gold stan-
dard to quantify the infarct size and the extend of microvascular obstruction in
ST-elevation myocardial infarction (STEMI). ST-segment resolution (STR)
after primary percutaneous intervention (PCI) is currently used to assess the
reperfusion quality in the acute phase myocardial infarction. The relation
between STR and microvascular obstruction evaluated by MRI is unknown.
The aim of this study was to determine the relationship between the ST-seg-
ment resolution, the infarct size and the extend of microvascular obstruction.
 
Methods:
 
 41 patients undergoing primary PCI for STEMI within 6 hours
of symptom onset were prospectively included. ST-segment resolution was
evaluated one hour after reperfusion. MRI was performed in all patients. Com-
plete STR was defined as a STR>70%.
 
Results:
 
 Mean age of the patients was 54 Â± 12 yo, 85 waer males. The
percent of infarct size was 18,6 Â±16% of the left ventricular volume.
Microvascular obstruction was present in 68% of patients. Mean STR was 59
Â± 39% and 14 patients (34%) presented complete STR. A large infarct size
(> 75
 
th
 
 percentile) was associated with anterior localisation and left descending
artery obstruction. STR significantly correlated with infarct size measured by
MRI (r=-0,38 p=0,026). Incomplete STR (<70%) predicted large infarct size
with a sensitivity of 78%, a specificity of 42% and high degree of microvas-
cular obstruction with sensitivity of 80% and specificity of 45%.
 
Conclusion:
 
 STR one hour after primary PCI is associated with the level
of infarct size and microvascular obstruction in STEMI patients. Incomplete
STR after PCI is a strong prognostic marker of large infarct size and high
degree of micro vascular obstruction.
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Background:
 
 The presence of preinfarction angina (PIA) has been shown
to confer cardioprotection after ST segment elevation myocardial infarction
(MI). However, the impact of PIA in non ST segment elevation (NSTEMI)
remains to be determined.
 
Patients and Methods:
 
 From the obseRvatoire des Infarctus de Côte d’Or
(RICO) survey, 1541 consecutive patients admitted in intensive care unit with
a first NSTEMI were included in the study. Patients who experienced chest
pain <7 days before the episode leading to admission were defined as having
PIA. Patients presenting with PIA were compared with patients without PIA.
Prehospital resuscitated cardiac arrest (RCA), incidence of in-hospital ventri-
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